Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Development of self-efficacy and expectancy measures for benzodiazepines
Addictive Behaviours, 06/25/09
Parr JM et al. - The scales provide reliable measures for assessing benzodiazepine self-efficacy and expectancies. Future research will examine the utility of the scales in prospective prediction of benzodiazepine cessation.
Methods- Internal structure of the questionnaires was established by principal component analysis (PCA) in a sample of 155 respondents, and verified by confirmatory factor analyses (CFA) in a second independent sample (n = 139) using structural equation modeling.
- The PCA of the BRSEQ resulted in a 16-item, 4-factor scale, and the BEQ formed an 18-item, 2-factor scale.
- Both scales were internally reliable.
- Lower self-efficacy and higher expectancy were moderately associated with higher scores on the SDS-B.
Related Articles
Psychometric Assessment of the Brazilian Version of the Breastfeeding Self-Efficacy Scale
Public Health Nursing, 11/10/09
Relevance Score: 64%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 62%
Comparison of trait and ability measures of emotional intelligence in medical students
Medical Education, 10/27/09
Relevance Score: 46%
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
Journal of Rheumatology, 10/15/09
Relevance Score: 46%
Self-Reported Adherence to Nonpharmacological Treatment and Association with Mortality over 6 Years: Population-Based Study in Older Persons with Hypercholesterolemia
Journal of the American Geriatrics Society, 10/28/09
Relevance Score: 45%
Today in Anxiety...keeping you current
Receive free subspecialty "5-minute updates" via email
Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression
Biological Psychiatry, 11/30/09
Do Treatment Improvements in PTSD Severity Affect Substance Use Outcomes? A Secondary Analysis From a Randomized Clinical Trial in NIDAs Clinical Trials Network
American Journal of Psychiatry, 11/30/09
Group Psychotherapy of Dysfunctional Fear of Progression in Patients with Chronic Arthritis or Cancer
Psychotherapy and Psychosomatics, 11/30/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data
BMC Psychiatry, 11/30/09
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Schizophrenia Bulletin, 11/30/09
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance
International Journal of Geriatric Psychiatry, 11/30/09
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
Personality Characteristics and Hypothalamic-Pituitary-Adrenal Axis Regulation in Older Persons
American Journal of Geriatric Psychiatry, 11/30/09
Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene
Neurological Sciences, 11/30/09
Metabolic Alterations in the Amygdala in Borderline Personality Disorder: A Proton Magnetic Resonance Spectroscopy Study
Biological Psychiatry, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


